CEACAM5 and cancer: Despite high infiltration of M1 macrophages and CD8+ T cells in the IFN-γ dominant pancreatic cancers [26], poor prognosis reflected the potential inhibitory effect of CEACAM5+ cancer cells on anti-cancer immunity in pancreatic cancer.